Form 4 Tracker
Christopher Gibson

Director · 10 filings · Latest: May 7, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Christopher GibsonDirectorMay 7, 2026
Sale
$3.3740,000$134.8K926,556
RXRX
Gibson ChristopherMay 7, 2026
Proposed Sale
$3.3740,000$134.8K
RXRX
Christopher GibsonDirectorApr 22, 2026
Sale
$3.6140,000$144.4K906,556
RXRX
Gibson ChristopherApr 22, 2026
Proposed Sale
$3.6140,000$144.4K
RXRX
Christopher GibsonDirectorApr 7, 2026
Sale
$3.1040,000$124.0K906,556
RXRX
Gibson ChristopherApr 7, 2026
Proposed Sale
$3.1040,000$124.0K
RXRX
Christopher GibsonDirectorMar 23, 2026
Sale
$3.2540,000$130.0K906,556
RXRX
Gibson ChristopherMar 23, 2026
Proposed Sale
$3.2540,000$130.0K
RXRX
Christopher GibsonDirectorFeb 19, 2026
Sale
$3.4640,000$138.4K906,556
RXRX
Gibson ChristopherFeb 19, 2026
Proposed Sale
$3.4640,000$138.4K
RXRX
Christopher GibsonDirectorFeb 4, 2026
Sale
$4.1240,000$164.8K913,839
RXRX
Gibson ChristopherFeb 4, 2026
Proposed Sale
$4.1240,000$164.8K
RXRX
Christopher GibsonDirectorJan 20, 2026
Sale
$4.4740,000$178.8K913,839
RXRX
Gibson ChristopherJan 20, 2026
Proposed Sale
$4.4740,000$178.8K
RXRX
Gibson ChristopherJan 5, 2026
Proposed Sale
$4.2540,000$170.0K
RXRX
Gibson ChristopherDec 19, 2025
Proposed Sale
$4.5040,000$180.0K
RXRX
Gibson ChristopherDec 4, 2025
Proposed Sale
$4.6340,000$185.2K
RXRX
Gibson ChristopherNov 19, 2025
Proposed Sale
$4.1640,000$166.4K
RXRX
Gibson ChristopherNov 4, 2025
Proposed Sale
$5.2140,000$208.4K
RXRX
Gibson ChristopherOct 23, 2025
Proposed Sale
$5.70100,000$570.0K

Page 1 of 2

Next →